Cardiovascular Business -- The SAMMPRIS trial, initiated to compare aggressive medical therapy alone to aggressive medical management plus angioplasty combined with stenting in patients with symptomatic high-grade stenosis (70 to 99 percent) of a major intracranial artery to prevent stroke, has been halted.
